The FDA has approved specific GLP-1 medications for type 2 diabetes management and, in higher doses, certain agents (semaglutide 2.4 mg, liraglutide 3 mg, tirzepatide) for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
They will offer tailored advice, track your progress, and make necessary adjustments to the treatment plan to achieve the best possible results
Patients should ask the prescribing clinician and the dispensing pharmacy specific questions about how the program plans to operate going forward, and should understand that compounded GLP-1 access may change as the regulatory framework evolves
Possible side effects of GLP-1s (Wegovy, Saxenda, Zepbound) Side effects tend to be focused on the gastrointestinal system, where these medications work by changing gut hormones
Are Kind Patches FDA-approved
Inject into your thigh or stomac h, and rotate injection sites to prevent irritation